2023 Q4 Form 10-Q Financial Statement

#000151597123000158 Filed on November 20, 2023

View on sec.gov

Income Statement

Concept 2023 Q4 2023 Q3
Revenue $4.902M $4.689M
YoY Change 2.29% -20.26%
Cost Of Revenue $4.568M $3.425M
YoY Change 62.95% -31.08%
Gross Profit $333.5K $1.264M
YoY Change -83.23% 38.75%
Gross Profit Margin 6.8% 26.96%
Selling, General & Admin $2.375M $944.7K
YoY Change 2.54% -50.51%
% of Gross Profit 712.14% 74.73%
Research & Development $185.4K
YoY Change 30.31%
% of Gross Profit 14.66%
Depreciation & Amortization $3.090K -$740.00
YoY Change 0.0% -124.03%
% of Gross Profit 0.93% -0.06%
Operating Expenses $1.888M $1.133M
YoY Change -8.95% -44.84%
Operating Profit -$1.555M $131.1K
YoY Change 1722.88% -111.47%
Interest Expense -$269.1K $210.0K
YoY Change 62.24% 29.64%
% of Operating Profit 160.22%
Other Income/Expense, Net $133.9K -$244.3K
YoY Change -19.91% 20.6%
Pretax Income -$1.690M -$113.2K
YoY Change 1911.17% -91.59%
Income Tax
% Of Pretax Income
Net Earnings -$1.690M -$113.2K
YoY Change 1911.17% -91.59%
Net Earnings / Revenue -34.48% -2.41%
Basic Earnings Per Share $0.00
Diluted Earnings Per Share -$0.04 $0.00
COMMON SHARES
Basic Shares Outstanding 42.96M shares 42.67M shares
Diluted Shares Outstanding 42.71M shares

Balance Sheet

Concept 2023 Q4 2023 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $777.1K $1.322M
YoY Change -62.2% -41.06%
Cash & Equivalents $777.1K $1.322M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory $1.230M $679.2K
Prepaid Expenses $129.7K $68.19K
Receivables $1.497M $1.254M
Other Receivables $0.00 $0.00
Total Short-Term Assets $3.633M $3.323M
YoY Change -12.52% -17.97%
LONG-TERM ASSETS
Property, Plant & Equipment $24.18K $27.27K
YoY Change -33.81% -31.17%
Goodwill
YoY Change
Intangibles $1.078M $634.3K
YoY Change -9.29% -48.22%
Long-Term Investments
YoY Change
Other Assets $74.54K $74.54K
YoY Change 0.9% -41.7%
Total Long-Term Assets $1.176M $1.188M
YoY Change -9.4% -15.27%
TOTAL ASSETS
Total Short-Term Assets $3.633M $3.323M
Total Long-Term Assets $1.176M $1.188M
Total Assets $4.810M $4.511M
YoY Change -11.78% -17.28%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $3.710M $1.984M
YoY Change 175.01% 37.23%
Accrued Expenses $127.7K $125.3K
YoY Change 7.89% 8.36%
Deferred Revenue
YoY Change
Short-Term Debt $3.655M $3.625M
YoY Change 19.02% 19.73%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $7.493M $5.734M
YoY Change 65.1% 24.96%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $330.5K $363.4K
YoY Change -27.87% -26.65%
Total Long-Term Liabilities $330.5K $363.4K
YoY Change -27.87% -26.65%
TOTAL LIABILITIES
Total Short-Term Liabilities $7.493M $5.734M
Total Long-Term Liabilities $330.5K $363.4K
Total Liabilities $7.823M $6.098M
YoY Change 56.57% 19.93%
SHAREHOLDERS EQUITY
Retained Earnings -$12.24M -$10.55M
YoY Change 47.49% 28.42%
Common Stock $43.15K $42.86K
YoY Change 2.14% 1.52%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$3.013M -$1.586M
YoY Change
Total Liabilities & Shareholders Equity $4.810M $4.511M
YoY Change -11.78% -17.28%

Cashflow Statement

Concept 2023 Q4 2023 Q3
OPERATING ACTIVITIES
Net Income -$1.690M -$113.2K
YoY Change 1911.17% -91.59%
Depreciation, Depletion And Amortization $3.090K -$740.00
YoY Change 0.0% -124.03%
Cash From Operating Activities -$594.5K $182.5K
YoY Change 175.48% -165.69%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00
YoY Change -100.0%
Cash From Investing Activities $0.00 $0.00
YoY Change -100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 49.50K 4.000K
YoY Change 171.23% -95.56%
NET CHANGE
Cash From Operating Activities -594.5K 182.5K
Cash From Investing Activities 0.000 0.000
Cash From Financing Activities 49.50K 4.000K
Net Change In Cash -545.0K 186.5K
YoY Change 190.58% -199.31%
FREE CASH FLOW
Cash From Operating Activities -$594.5K $182.5K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Entity Central Index Key
EntityCentralIndexKey
0000845819
CY2023Q3 us-gaap Other Assets Current
OtherAssetsCurrent
usd
CY2022Q3 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
usd
ktel Noncompensatory Stock Options Exercised
NoncompensatoryStockOptionsExercised
usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
usd
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
usd
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-09-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-10171
dei Entity Registrant Name
EntityRegistrantName
KonaTel, Inc.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
80-0973608
dei Entity Address Address Line1
EntityAddressAddressLine1
500 N. Central Expressway
dei Entity Address Address Line2
EntityAddressAddressLine2
Ste. 202
dei Entity Address City Or Town
EntityAddressCityOrTown
Plano
dei Entity Address State Or Province
EntityAddressStateOrProvince
TX
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
75074
dei City Area Code
CityAreaCode
214
dei Local Phone Number
LocalPhoneNumber
323-8410
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2023Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
42958220 shares
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1322119 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2055634 usd
CY2023Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1253715 usd
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1510118 usd
CY2023Q3 us-gaap Inventory Net
InventoryNet
679185 usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
526337 usd
CY2023Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
68194 usd
CY2022Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
61241 usd
CY2022Q4 us-gaap Other Assets Current
OtherAssetsCurrent
164 usd
CY2023Q3 us-gaap Assets Current
AssetsCurrent
3323213 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
4153494 usd
CY2023Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
27272 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
36536 usd
CY2023Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
634251 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
634251 usd
CY2023Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
452118 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
553686 usd
CY2023Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
74543 usd
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
73883 usd
CY2023Q3 ktel Total Other Assets
TotalOtherAssets
1160912 usd
CY2022Q4 ktel Total Other Assets
TotalOtherAssets
1261820 usd
CY2023Q3 us-gaap Assets
Assets
4511397 usd
CY2022Q4 us-gaap Assets
Assets
5451850 usd
CY2023Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
1984266 usd
CY2022Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
1348931 usd
CY2023Q3 us-gaap Loans Payable Current
LoansPayableCurrent
3624838 usd
CY2022Q4 us-gaap Loans Payable Current
LoansPayableCurrent
3070947 usd
CY2023Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
125324 usd
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
118382 usd
CY2023Q3 us-gaap Liabilities Current
LiabilitiesCurrent
5734428 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
4538260 usd
CY2023Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
363355 usd
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
458227 usd
CY2023Q3 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
363355 usd
CY2022Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
458227 usd
CY2023Q3 us-gaap Liabilities
Liabilities
6097783 usd
CY2022Q4 us-gaap Liabilities
Liabilities
4996487 usd
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000 shares
CY2023Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
42858220 shares
CY2023Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
42858220 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
42240406 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
42240406 shares
CY2023Q3 us-gaap Common Stock Value
CommonStockValue
42858 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
42240 usd
CY2023Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
8919253 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
8710987 usd
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-10548497 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-8297864 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
-1586386 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
455363 usd
CY2023Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
4511397 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
5451850 usd
CY2023Q3 us-gaap Revenues
Revenues
4689001 usd
CY2022Q3 us-gaap Revenues
Revenues
5880333 usd
us-gaap Revenues
Revenues
13322146 usd
us-gaap Revenues
Revenues
15231288 usd
CY2023Q3 us-gaap Cost Of Revenue
CostOfRevenue
3424832 usd
CY2022Q3 us-gaap Cost Of Revenue
CostOfRevenue
4969251 usd
us-gaap Cost Of Revenue
CostOfRevenue
10282046 usd
us-gaap Cost Of Revenue
CostOfRevenue
12230378 usd
CY2023Q3 us-gaap Gross Profit
GrossProfit
1264169 usd
CY2022Q3 us-gaap Gross Profit
GrossProfit
911082 usd
us-gaap Gross Profit
GrossProfit
3040100 usd
us-gaap Gross Profit
GrossProfit
3000910 usd
CY2023Q3 us-gaap Labor And Related Expense
LaborAndRelatedExpense
686560 usd
CY2022Q3 us-gaap Labor And Related Expense
LaborAndRelatedExpense
1348152 usd
us-gaap Labor And Related Expense
LaborAndRelatedExpense
2933409 usd
us-gaap Labor And Related Expense
LaborAndRelatedExpense
3719446 usd
CY2023Q3 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
1242 usd
CY2022Q3 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
5321 usd
us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
4563 usd
us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
6681 usd
CY2023Q3 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
200 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
214 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
29133 usd
CY2023Q3 us-gaap Professional And Contract Services Expense
ProfessionalAndContractServicesExpense
113546 usd
CY2022Q3 us-gaap Professional And Contract Services Expense
ProfessionalAndContractServicesExpense
381340 usd
us-gaap Professional And Contract Services Expense
ProfessionalAndContractServicesExpense
576964 usd
us-gaap Professional And Contract Services Expense
ProfessionalAndContractServicesExpense
675987 usd
CY2023Q3 us-gaap Other General Expense
OtherGeneralExpense
53814 usd
CY2022Q3 us-gaap Other General Expense
OtherGeneralExpense
60083 usd
us-gaap Other General Expense
OtherGeneralExpense
162889 usd
us-gaap Other General Expense
OtherGeneralExpense
135118 usd
CY2023Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
3088 usd
CY2022Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
3088 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
9264 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
9264 usd
CY2023Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
35459 usd
CY2022Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
71545 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
120103 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
251778 usd
CY2023Q3 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
36633 usd
CY2022Q3 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
15542 usd
us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
120640 usd
us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
100570 usd
CY2023Q3 ktel Application Development Costs
ApplicationDevelopmentCosts
185350 usd
CY2022Q3 ktel Application Development Costs
ApplicationDevelopmentCosts
142237 usd
ktel Application Development Costs
ApplicationDevelopmentCosts
628508 usd
ktel Application Development Costs
ApplicationDevelopmentCosts
391930 usd
CY2023Q3 us-gaap Real Estate Taxes And Insurance
RealEstateTaxesAndInsurance
17214 usd
CY2022Q3 us-gaap Real Estate Taxes And Insurance
RealEstateTaxesAndInsurance
26729 usd
us-gaap Real Estate Taxes And Insurance
RealEstateTaxesAndInsurance
49225 usd
us-gaap Real Estate Taxes And Insurance
RealEstateTaxesAndInsurance
150389 usd
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
1133106 usd
CY2022Q3 us-gaap Operating Expenses
OperatingExpenses
2054037 usd
us-gaap Operating Expenses
OperatingExpenses
4605779 usd
us-gaap Operating Expenses
OperatingExpenses
5470296 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
131063 usd
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-1142955 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-1565679 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-2469386 usd
CY2023Q3 us-gaap Interest Expense
InterestExpense
209991 usd
CY2022Q3 us-gaap Interest Expense
InterestExpense
161977 usd
us-gaap Interest Expense
InterestExpense
551123 usd
us-gaap Interest Expense
InterestExpense
233153 usd
CY2023Q3 us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
34288 usd
CY2022Q3 us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
40582 usd
us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
133831 usd
us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
165778 usd
CY2023Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-244279 usd
CY2022Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-202559 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-684954 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-398931 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-113216 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-1345514 usd
us-gaap Net Income Loss
NetIncomeLoss
-2250633 usd
us-gaap Net Income Loss
NetIncomeLoss
-2868317 usd
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.03
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.05
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.07
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.03
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.05
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.07
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
42707808 shares
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
41912145 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
42658697 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
41715406 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
42707808 shares
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
41912145 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
42658697 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
41715406 shares
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
455363 usd
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
123751 usd
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
85133 usd
us-gaap Net Income Loss
NetIncomeLoss
-2250633 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
-1586386 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-1316984 usd
CY2023Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
41250 usd
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
-197436 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-113216 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
-1586386 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
2607335 usd
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
90000 usd
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
539933 usd
us-gaap Net Income Loss
NetIncomeLoss
-2868317 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
368951 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
1438828 usd
CY2022Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
90000 usd
CY2022Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
185637 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-1345514 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
368951 usd
us-gaap Net Income Loss
NetIncomeLoss
-2250633 usd
us-gaap Net Income Loss
NetIncomeLoss
-2868317 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
9264 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
9264 usd
us-gaap Amortization Of Deferred Loan Origination Fees Net
AmortizationOfDeferredLoanOriginationFeesNet
-131141 usd
us-gaap Amortization Of Deferred Loan Origination Fees Net
AmortizationOfDeferredLoanOriginationFeesNet
-51095 usd
us-gaap Provision For Other Losses
ProvisionForOtherLosses
214 usd
us-gaap Provision For Other Losses
ProvisionForOtherLosses
29133 usd
us-gaap Share Based Compensation
ShareBasedCompensation
85133 usd
us-gaap Share Based Compensation
ShareBasedCompensation
539933 usd
ktel Noncompensatory Stock Options Exercised
NoncompensatoryStockOptionsExercised
82500 usd
ktel Change In Right Of Use Asset
ChangeInRightOfUseAsset
-101568 usd
ktel Change In Right Of Use Asset
ChangeInRightOfUseAsset
417014 usd
ktel Change In Lease Liability
ChangeInLeaseLiability
-87930 usd
ktel Change In Lease Liability
ChangeInLeaseLiability
423920 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-256189 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
257500 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
152848 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-269445 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
7448 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-98456 usd
us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
635335 usd
us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
515527 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1197515 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1606058 usd
us-gaap Proceeds From Short Term Debt
ProceedsFromShortTermDebt
500000 usd
us-gaap Proceeds From Short Term Debt
ProceedsFromShortTermDebt
3150000 usd
us-gaap Payments Of Loan Costs
PaymentsOfLoanCosts
77250 usd
us-gaap Payments Of Loan Costs
PaymentsOfLoanCosts
173532 usd
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
150000 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
41250 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
90000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
464000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
2916468 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-733515 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
1310410 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
2055634 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
932785 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1322119 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
2243195 usd
us-gaap Interest Paid Net
InterestPaidNet
167900 usd
us-gaap Interest Paid Net
InterestPaidNet
3099 usd
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
870684 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1936189 shares
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-113216 usd
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P1Y7M2D
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-1345514 usd
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
42707808 shares
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
41912145 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
42707808 shares
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
41912145 shares
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.03
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.03
us-gaap Net Income Loss
NetIncomeLoss
-2250633 usd
us-gaap Net Income Loss
NetIncomeLoss
-2868317 usd
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
42658697 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
41715406 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
42658697 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
41715406 shares
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.05
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.07
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.05
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.07
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p id="xdx_84F_eus-gaap--ConcentrationRiskCreditRisk_zsvG6843hwV8" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Concentrations of Credit Risk</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="xdx_912_eus-gaap--TradeAccountsReceivableMember_zVk5VWhqqFVl" style="display: none">Trade Account Receivables</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="xdx_916_eus-gaap--SalesRevenueNetMember_z7wHvwmtcn4e" style="display: none">Sales Revenue</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="xdx_910_eus-gaap--CustomerConcentrationRiskMember_zGAfkpHasp4g" style="display: none">Customer Concentration</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Financial instruments, which potentially subject the Company to concentrations of credit risk, consist primarily of receivables, cash and cash equivalents.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">All cash and cash equivalents are held at high credit financial institutions. These deposits are generally insured under the FDIC’s deposit insurance coverage; however, from time to time, the deposit levels may exceed FDIC coverage levels.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company has a concentration of risk with respect to trade receivables from customers and cellular providers. As of September 30, 2023, the Company had a significant concentration of receivables (defined as customers whose receivable balances are greater than 10% of total receivables) due from two (2) customers in the amount of $<span id="xdx_90F_eus-gaap--FairValueConcentrationOfRiskAccountsReceivable_iI_c20230930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--TradeAccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__custom--SpecificCustomerConcentrationAxis__custom--CustomerOneMember_zKe57jGIm9r6" title="Receivables, concentration">889,249</span> or <span id="xdx_903_eus-gaap--ConcentrationRiskPercentage1_dp_c20230101__20230930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--TradeAccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__custom--SpecificCustomerConcentrationAxis__custom--CustomerOneMember_zXvP7fUfDdu5" title="Concentration risk">70.9</span>%, and $<span id="xdx_905_eus-gaap--FairValueConcentrationOfRiskAccountsReceivable_iI_c20230930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--TradeAccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__custom--SpecificCustomerConcentrationAxis__custom--CustomerTwoMember_zQgPNcFsLs14" title="Receivables, concentration">202,548</span> or <span id="xdx_90B_eus-gaap--ConcentrationRiskPercentage1_dp_c20230101__20230930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--TradeAccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__custom--SpecificCustomerConcentrationAxis__custom--CustomerTwoMember_zeVvX4Xydoej" title="Concentration risk">16.2</span>%. It should be noted that the largest customer is the federal government, as administered by the Universal Service Administrative Company (“USAC”), under the authority of the Federal Communication Commission (the “FCC”). As of December 31, 2022, the Company had a significant concentration of receivables from two (2) customers in the amounts of $<span id="xdx_900_eus-gaap--FairValueConcentrationOfRiskAccountsReceivable_iI_c20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--TradeAccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__custom--SpecificCustomerConcentrationAxis__custom--CustomerOneMember_zIYOhZxyEwzh" title="Receivables, concentration">859,334</span> or <span id="xdx_905_eus-gaap--ConcentrationRiskPercentage1_dp_c20220101__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--TradeAccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__custom--SpecificCustomerConcentrationAxis__custom--CustomerOneMember_zrujAHxv1GNi" title="Concentration risk">57.0</span>%, and $<span id="xdx_900_eus-gaap--FairValueConcentrationOfRiskAccountsReceivable_iI_c20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--TradeAccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__custom--SpecificCustomerConcentrationAxis__custom--CustomerTwoMember_zdr8Kz8qf7W1" title="Receivables, concentration">255,136</span> or <span id="xdx_905_eus-gaap--ConcentrationRiskPercentage1_dp_c20220101__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--TradeAccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__custom--SpecificCustomerConcentrationAxis__custom--CustomerTwoMember_zsws1H0iDFeh" title="Concentration risk">16.9</span>%.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt/107% Times New Roman, Times, Serif; margin: 0 0 8pt"><i></i></p>
us-gaap Net Income Loss
NetIncomeLoss
-2250633 usd
us-gaap Net Income Loss
NetIncomeLoss
-2868317 usd
CY2022Q2 us-gaap Short Term Borrowings
ShortTermBorrowings
3150000 usd
CY2023Q2 us-gaap Debt Instrument Unused Borrowing Capacity Amount
DebtInstrumentUnusedBorrowingCapacityAmount
2000000 usd
CY2023Q2 us-gaap Proceeds From Short Term Debt
ProceedsFromShortTermDebt
500000 usd
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-10548497 usd
CY2022Q4 us-gaap Short Term Borrowings
ShortTermBorrowings
3150000 usd
CY2023Q3 us-gaap Inventory Net
InventoryNet
679185 usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
526337 usd
CY2023Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
461611 usd
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
461611 usd
CY2023Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
434339 usd
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
425075 usd
CY2023Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
27272 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
36536 usd
us-gaap Lessee Operating Lease Description
LesseeOperatingLeaseDescription
the Company had four (4) properties with lease terms in excess of one (1) year. Of these four (4) leases, two (2) leases expire in 2025, one (1) lease expires in 2026, and one (1) lease expires in 2030
CY2023Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
488679 usd
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
38565 usd
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
155325 usd
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
129543 usd
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
65967 usd
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
54000 usd
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
144000 usd
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
587400 usd
CY2023Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
98721 usd
CY2023Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
488679 usd
CY2023Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
125324 usd
CY2023Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
363355 usd
CY2023Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P62M6D
CY2023Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0684 pure
CY2023Q3 us-gaap Operating Lease Expense
OperatingLeaseExpense
42503 usd
CY2022Q3 us-gaap Operating Lease Expense
OperatingLeaseExpense
33663 usd
us-gaap Operating Lease Expense
OperatingLeaseExpense
128582 usd
us-gaap Operating Lease Expense
OperatingLeaseExpense
93260 usd
CY2023Q3 us-gaap Finite Lived Intangible Assets Fair Value Disclosure
FiniteLivedIntangibleAssetsFairValueDisclosure
634251 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Fair Value Disclosure
FiniteLivedIntangibleAssetsFairValueDisclosure
634251 usd
CY2023Q3 us-gaap Finite Lived Customer Lists Gross
FiniteLivedCustomerListsGross
1135962 usd
CY2022Q4 us-gaap Finite Lived Customer Lists Gross
FiniteLivedCustomerListsGross
1135962 usd
CY2023Q3 us-gaap Capitalized Computer Software Gross
CapitalizedComputerSoftwareGross
2407001 usd
CY2022Q4 us-gaap Capitalized Computer Software Gross
CapitalizedComputerSoftwareGross
2407001 usd
CY2023Q3 us-gaap Finite Lived License Agreements Gross
FiniteLivedLicenseAgreementsGross
634251 usd
CY2022Q4 us-gaap Finite Lived License Agreements Gross
FiniteLivedLicenseAgreementsGross
634251 usd
CY2023Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
3542963 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
3542963 usd
CY2023Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
634251 usd
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
634251 usd
CY2023Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
0 usd
CY2022Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
0 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
0 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
0 usd
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
4642500 shares
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.65
ktel Weighted Average Remaining Life At End Of Period
WeightedAverageRemainingLifeAtEndOfPeriod
P3Y8M8D
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
256288 usd
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
870684 shares
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
0.45
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2 number
us-gaap Revenues
Revenues
13322146 usd
us-gaap Gross Profit
GrossProfit
3040100 usd
us-gaap Other Depreciation And Amortization
OtherDepreciationAndAmortization
9264 usd
us-gaap Property Plant And Equipment Additions
PropertyPlantAndEquipmentAdditions
0 usd
CY2023Q3 us-gaap Revenues
Revenues
4689001 usd
CY2023Q3 us-gaap Gross Profit
GrossProfit
1264169 usd
CY2023Q3 us-gaap Other Depreciation And Amortization
OtherDepreciationAndAmortization
3088 usd
CY2023Q3 us-gaap Property Plant And Equipment Additions
PropertyPlantAndEquipmentAdditions
0 usd
us-gaap Revenues
Revenues
15231288 usd
us-gaap Gross Profit
GrossProfit
3000910 usd
us-gaap Other Depreciation And Amortization
OtherDepreciationAndAmortization
9264 usd
us-gaap Property Plant And Equipment Additions
PropertyPlantAndEquipmentAdditions
0 usd
CY2022Q3 us-gaap Revenues
Revenues
5880333 usd
CY2022Q3 us-gaap Gross Profit
GrossProfit
911082 usd
CY2022Q3 us-gaap Other Depreciation And Amortization
OtherDepreciationAndAmortization
3088 usd
CY2022Q3 us-gaap Property Plant And Equipment Additions
PropertyPlantAndEquipmentAdditions
0 usd
us-gaap Stock Option Plan Expense
StockOptionPlanExpense
85133 usd
us-gaap Stock Option Plan Expense
StockOptionPlanExpense
539933 usd
CY2023Q3 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
197436 usd
CY2022Q3 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
185637 usd
us-gaap Deferred Compensation Arrangement With Individual Allocated Share Based Compensation Expense
DeferredCompensationArrangementWithIndividualAllocatedShareBasedCompensationExpense
1654950 usd
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P3Y2M8D
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
4405000 shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.59
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P3Y2M19D
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
2260138 usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
1600000 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0.81
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
662500 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0.53
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
700000 shares
CY2023Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
214347 usd

Files In Submission

Name View Source Status
0001515971-23-000158-index-headers.html Edgar Link pending
0001515971-23-000158-index.html Edgar Link pending
0001515971-23-000158.txt Edgar Link pending
0001515971-23-000158-xbrl.zip Edgar Link pending
exhibit311.htm Edgar Link pending
exhibit312.htm Edgar Link pending
exhibit32.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
ktel-20230930.xsd Edgar Link pending
ktel10q093023.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
ktel-20230930_cal.xml Edgar Link unprocessable
ktel-20230930_def.xml Edgar Link unprocessable
ktel-20230930_lab.xml Edgar Link unprocessable
ktel-20230930_pre.xml Edgar Link unprocessable
ktel10q093023_htm.xml Edgar Link completed
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending